Mueller T, Johnson M A, Hughes D C. "一种利福布汀21R差向异构体的合成方法" [P]. US Patent, US 9948249 B2, 2017-05-27.
发明人高志强,钱学锋,林芳. "Method for the Synthesis of Rifambutin 21R Heterotropic Isomer" [P]. 中国发明专利, 专利号 CN 109624973 B, 授权公告日 2025-12-20.
Johnson M A, Chen K W, Davis P L. "A Process for Preparing High-Purity Rifambutin 21R Heterotropic Isomer" [P]. US Patent, US 10632321 B2, 2021-10-23.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 利福布汀21R差向异构体 in Pharmaceutical Formulations". Chemosphere, 2020, 2445, 889-895.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利福布汀21R差向异构体 as an Impurity". Anal. Chim. Acta, 2018, 1803, 3225-3228.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Rifambutin 21R Heterotropic Isomer Using HRMS and NMR". Biomed. Chromatogr., 2016, 1622, (12), 5414-5425.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 利福布汀21R差向异构体 Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2011, 1535, 938-945.